Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.

Alessandro MenozziManuel Dall'AglioFausto QuintavallaLuca DallavalleValentina MeucciSimone Bertini

Published in: BMC veterinary research (2016)

The present study showed, for the first time, that oral rifaximin could represent an effective alternative to metronidazole for the induction of clinical remission in dogs with chronic enteropathy.

Keyphrases

irritable bowel syndrome
study protocol
clinical trial
disease activity
systemic lupus erythematosus
drug induced
rheumatoid arthritis
replacement therapy
double blind